Chronic rhinosinusitis and sleep: A contemporary review

International Forum of Allergy and Rhinology

Volumn 3, Issue 11, 2013, Pages 941-949

  Alt, Jeremiah A ^a   Smith, Timothy L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Fatigue; Review; Rhinology; Sinusitis; Sleep

Indexed keywords

ALPHA INTERFERON; ANTIHISTAMINIC AGENT; CORTICOSTEROID; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; NITRIC OXIDE; PROLACTIN; PROSTAGLANDIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ALLERGIC RHINITIS; APNEA HYPOPNEA INDEX; ARTICLE; CHRONIC RHINOSINUSITIS; COMPARATIVE STUDY; CORTICOSTEROID THERAPY; DAYTIME SOMNOLENCE; FATIGUE; HUMAN; META ANALYSIS (TOPIC); NEUROIMMUNOLOGY; NONREM SLEEP; NOSE OBSTRUCTION; NOSE POLYP; PATHOPHYSIOLOGY; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; SLEEP; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SNORING;

FATIGUE; REVIEW; RHINOLOGY; SINUSITIS; SLEEP;

CHRONIC DISEASE; CYTOKINES; FATIGUE; HUMANS; NASAL OBSTRUCTION; RHINITIS; SINUSITIS; SLEEP DISORDERS;

EID: 84888058473     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21217     Document Type: Article

References (127)

1. Colten HR, Altevogt BM, eds; Committee on Sleep Medicine and Research. Sleep disorders and Sleep Deprivation: An Unmet Public Health Problem. Washington, DC: National Academic Press; 2006.
2. Alt JA, Smith TL, Mace JC, Soler ZM. Sleep quality and disease severity in patients with chronic rhinosinusitis. The Laryngoscope. 2013;123:2364-2370. DOI: 10.1002/lary.24040
3. Wells ME, Vaughn BV. Poor sleep challenging the health of a Nation. Neurodiagn J. 2012;52:233-249.
4. Serrano E, Neukirch F, Pribil C, et al. Nasal polyposis in France: impact on sleep and quality of life. J Laryngol Otol. 2005;119:543-549.
5. Opp MR, Obal F Jr, Krueger JM. Interleukin 1 alters rat sleep: temporal and dose-related effects. Am J Physiol. 1991;260:R52-R58.
6. Otto BA, Wenzel SE. The role of cytokines in chronic rhinosinusitis with nasal polyps. Curr Opin Otolaryngol Head Neck Surg. 2008;16:270-274.
7. Krueger JM. The role of cytokines in sleep regulation. Curr Pharm Des. 2008;14:3408-3416.
8. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci. 2001;933:222-234.
9. Alt JA, Obal F Jr, Traynor TR, Gardi J, Majde JA, Krueger JM. Alterations in EEG activity and sleep after influenza viral infection in GHRH receptor-deficient mice. J Appl Physiol. 2003;95:460-468.
10. Benninger MS, Benninger RM. The impact of allergic rhinitis on sexual activity, sleep, and fatigue. Allergy Asthma Proc. 2009;30:358-365.
11. Benninger MS, Senior BA. The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg. 1997;123:1175-1179.
12. Piccirillo JF, Merritt MG Jr, Richards ML. Psychometric and clinimetric validity of the 20-item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg. 2002;126:41-47.
13. Piccirillo J, Edwards D, Haiduk A. Psychometric and clinimetric validity of the 31 item Rhinosinusitis Outcome Measure (RSOM-31). Am J Rhinol. 1995;9:297-306.
14. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540-545.
15. Flemons WW, Reimer MA. Measurement properties of the Calgary sleep apnea quality of life index. Am J Respir Crit Care Med. 2002;165:159-164.
16. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213.
17. Neu D, Mairesse O, Hoffmann G, et al. Do "sleepy" and "tired" go together? Rasch analysis of the relationships between sleepiness, fatigue and nonrestorative sleep complaints in a nonclinical population sample. Neuroepidemiology. 2010;35:1-11.
18. Patarca R. Cytokines and chronic fatigue syndrome. Ann N Y Acad Sci. 2001;933:185-200.
19. Soler ZM, Smith TL. Quality of life outcomes after functional endoscopic sinus surgery. Otolaryngol Clin North Am. 2010;43:605-612.
20. Chester AC, Sindwani R, Smith TL, Bhattacharyya N. Fatigue improvement following endoscopic sinus surgery: a systematic review and meta-analysis. Laryngoscope. 2008;118:730-739.
21. Sautter NB, Mace J, Chester AC, Smith TL. The effects of endoscopic sinus surgery on level of fatigue in patients with chronic rhinosinusitis. Am J Rhinol. 2008;22:420-426.
22. Graff LA, Vincent N, Walker JR, et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:1882-1889.
23. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008;26:971-982.
24. Berger AM, Farr L. The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncol Nurs Forum. 1999;26:1663-1671.
25. Neu D, Linkowski P, le Bon O. Clinical complaints of daytime sleepiness and fatigue: how to distinguish and treat them, especially when they become "excessive" or "chronic"? Acta Neurol Belg. 2010;110:15-25.
26. Zwillich CW, Pickett C, Hanson FN, Weil JV. Disturbed sleep and prolonged apnea during nasal obstruction in normal men. Am Rev Respir Dis. 1981;124:158-160.
27. Suratt PM, Turner BL, Wilhoit SC. Effect of intranasal obstruction on breathing during sleep. Chest. 1986;90:324-329.
28. Olsen KD, Kern EB. Nasal influences on snoring and obstructive sleep apnea. Mayo Clin Proc. 1990;65:1095-1105.
29. Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol. 1997;99:S757-S762.
30. Stradling JR, Crosby JH. Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax. 1991;46:85-90.
31. Tosun F, Kemikli K, Yetkin S, Ozgen F, Durmaz A, Gerek M. Impact of endoscopic sinus surgery on sleep quality in patients with chronic nasal obstruction due to nasal polyposis. J Craniofac Surg. 2009;20:446-449.
32. Fokkens W, Lund V, Bachert C, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy. 2005;60:583-601.
33. Soler ZM, Mace J, Smith TL. Symptom-based presentation of chronic rhinosinusitis and symptom-specific outcomes after endoscopic sinus surgery. Am J Rhinol. 2008;22:297-301.
34. Lavie P, Gertner R, Zomer J, Podoshin L. Breathing disorders in sleep associated with "microarousals" in patients with allergic rhinitis. Acta Otolaryngol. 1981;92:529-533.
35. McNicholas WT, Tarlo S, Cole P, et al. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis. 1982;126:625-628.
36. Nakata S, Noda A, Yasuma F, et al. Effects of nasal surgery on sleep quality in obstructive sleep apnea syndrome with nasal obstruction. Am J Rhinol. 2008;22:59-63.
37. Li HY, Lee LA, Wang PC, Chen NH, Lin Y, Fang TJ. Nasal surgery for snoring in patients with obstructive sleep apnea. Laryngoscope. 2008;118:354-359.
38. Lindemann J, Keck T, Leiacker R, Dzida R, Wiesmiller K. Early influence of bilateral turbinoplasty combined with septoplasty on intranasal air conditioning. Am J Rhinol. 2008;22:542-545.
39. Li HY, Wang PC, Chen YP, Lee LA, Fang TJ, Lin HC. Critical appraisal and meta-analysis of nasal surgery for obstructive sleep apnea. Am J Rhinol Allergy. 2011;25:45-49.
40. Li HY, Lin Y, Chen NH, Lee LA, Fang TJ, Wang PC. Improvement in quality of life after nasal surgery alone for patients with obstructive sleep apnea and nasal obstruction. Arch Otolaryngol Head Neck Surg. 2008;134:429-433.
41. Craig TJ, Mende C, Hughes K, Kakumanu S, Lehman EB, Chinchilli V. The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Allergy Asthma Proc. 2003;24:53-58.
42. Craig TJ, Teets S, Lehman EB, Chinchilli VM, Zwillich C. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol. 1998;101:633-637.
43. Gurevich F, Glass C, Davies M, et al. The effect of intranasal steroid budesonide on the congestion-related sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis. Allergy Asthma Proc. 2005;26:268-274.
44. Hughes K, Glass C, Ripchinski M, et al. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy. 2003;58:380-385.
45. Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax. 2004;59:50-55.
46. Mintz M, Garcia J, Diener P, Liao Y, Dupclay L, Georges G. Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study. Ann Allergy Asthma Immunol. 2004;92:255-261.
47. Kakumanu SS, Mende CN, Lehman EB, Hughes K, Craig TJ. Effect of topical nasal corticosteroids on patients with chronic fatigue syndrome and rhinitis. J Am Osteopath Assoc. 2003;103:423-427.
48. Colas C, Galera H, Anibarro B, et al. Disease severity impairs sleep quality in allergic rhinitis (The SOMNIAAR study). Clin Exp Allergy. 2012;42:1080-1087.
49. Ishimori K. True cause of sleep: a hypnogenic substance as evidenced in the brain of sleep-deprived animals. Tokyo Igakkai Zasshi. 1909;23:429-459.
50. Krueger JM, Obal F Jr, Fang J. Why we sleep: a theoretical view of sleep function. Sleep Med Rev. 1999;3:119-129.
51. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev. 1999;79:1-71.
52. Quan N, Banks WA. Brain-immune communication pathways. Brain Behav Immun. 2007;21:727-735.
53. Bolger WE, Leonard D, Dick EJ Jr, Stierna P. Gram negative sinusitis: a bacteriologic and histologic study in rabbits. Am J Rhinol. 1997;11:15-25.
54. Ophir D, Hahn T, Schattner A, Wallach D, Aviel A. Tumor necrosis factor in middle ear effusions. Arch Otolaryngol Head Neck Surg. 1988;114:1256-1258.
55. Higgins GC, Foster JL, Postlethwaite AE. Interleukin 1 beta propeptide is detected intracellularly and extracellularly when human monocytes are stimulated with LPS in vitro. J Exp Med. 1994;180:607-614.
56. Kim DH, Jeon EJ, Park SN, Park KH, Park YS, Yeo SW. Effects of a tumor necrosis factor-alpha antagonist on experimentally induced rhinosinusitis. J Biomed Biotechnol. 2011;2011:360457.
57. Erbek SS, Yurtcu E, Erbek S, Atac FB, Sahin FI, Cakmak O. Proinflammatory cytokine single nucleotide polymorphisms in nasal polyposis. Arch Otolaryngol Head Neck Surg. 2007;133:705-709.
58. Mfuna Endam L, Cormier C, Bosse Y, Filali-Mouhim A, Desrosiers M. Association of IL1A, IL1B, and TNF gene polymorphisms with chronic rhinosinusitis with and without nasal polyposis: a replication study. Arch Otolaryngol Head Neck Surg. 2010;136:187-192.
59. Cormier C, Bosse Y, Mfuna L, Hudson TJ, Desrosiers M. Polymorphisms in the tumour necrosis factor alpha-induced protein 3 (TNFAIP3) gene are associated with chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2009;38:133-141.
60. Karosi T, Csomor P, Sziklai I. Tumor necrosis factor-alpha receptor expression correlates with mucosal changes and biofilm presence in chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2012;122:504-510.
61. Lin SK, Kok SH, Shun CT, et al. Tumor necrosis factor-alpha stimulates the expression of C-C chemokine ligand 2 gene in fibroblasts from the human nasal polyp through the pathways of mitogen-activated protein kinase. Am J Rhinol. 2007;21:251-255.
62. Lennard CM, Mann EA, Sun LL, Chang AS, Bolger WE. Interleukin-1 beta, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis: response to systemic corticosteroids. Am J Rhinol. 2000;14:367-373.
63. Obal F Jr, Krueger JM. Biochemical regulation of non-rapid-eye-movement sleep. Front Biosci. 2003;8:d520-d550.
64. Thomas KS, Motivala S, Olmstead R, Irwin MR. Sleep depth and fatigue: role of cellular inflammatory activation. Brain Behav Immun. 2010;25:53-58.
65. Omdal R, Gunnarsson R. The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis-a pilot study. Rheumatol Int. 2005;25:481-484.
66. Illi J, Miaskowski C, Cooper B, et al. Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. Cytokine. 2012;58:437-447.
67. Anisman H, Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann Med. 2003;35:2-11.
68. Baune BT, Ponath G, Rothermundt M, Riess O, Funke H, Berger K. Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study. Psychoneuroendocrinology. 2008;33:68-76.
69. Palin K, Bluthe RM, Verrier D, Tridon V, Dantzer R, Lestage J. Interleukin-1beta mediates the memory impairment associated with a delayed type hypersensitivity response to bacillus Calmette-Guerin in the rat hippocampus. Brain Behav Immun. 2004;18:223-230.
70. Opp MR, Krueger JM. Interleukin-1 is involved in responses to sleep deprivation in the rabbit. Brain Res. 1994;639:57-65.
71. Fang J, Wang Y, Krueger JM. Effects of interleukin-1 beta on sleep are mediated by the type I receptor. Am J Physiol. 1998;274:R655-R660.
72. Susic V, Totic S. "Recovery" function of sleep: effects of purified human interleukin-1 on the sleep and febrile response of cats. Metab Brain Dis. 1989;4:73-80.
73. Lue FA, Bail M, Jephthah-Ochola J, Carayanniotis K, Gorczynski R, Moldofsky H. Sleep and cerebrospinal fluid interleukin-1-like activity in the cat. Int J Neurosci. 1988;42:179-183.
74. Floyd RA, Krueger JM. Diurnal variation of TNF alpha in the rat brain. Neuroreport. 1997;8:915-918.
75. Darko DF, Miller JC, Gallen C, et al. Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor alpha, and human immunodeficiency virus infection. Proc Natl Acad Sci U S A. 1995;92:12080-12084.
76. Farrar WL, Kilian PL, Ruff MR, Hill JM, Pert CB. Visualization and characterization of interleukin 1 receptors in brain. J Immunol. 1987;139:459-463.
77. Fang J, Wang Y, Krueger JM. Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFalpha treatment. J Neurosci. 1997;17:5949-5955.
78. Szymusiak R, Steininger T, Alam N, McGinty D. Preoptic area sleep-regulating mechanisms. Arch Ital Biol. 2001;139:77-92.
79. Alam MN, McGinty D, Bashir T, et al. Interleukin-1beta modulates state-dependent discharge activity of preoptic area and basal forebrain neurons: role in sleep regulation. Eur J Neurosci. 2004;20:207-216.
80. Kubota T, Li N, Guan Z, Brown RA, Krueger JM. Intrapreoptic microinjection of TNF-alpha enhances non-REM sleep in rats. Brain Res. 2002;932:37-44.
81. Terao A, Matsumura H, Saito M. Interleukin-1 induces slow-wave sleep at the prostaglandin D2-sensitive sleep-promoting zone in the rat brain. J Neurosci. 1998;18:6599-6607.
82. Tashiro M, Mochizuki H, Iwabuchi K, et al. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life Sci. 2002;72:409-414.
83. Okuda M, Watase T, Mezawa A, Liu CM. The role of leukotriene D4 in allergic rhinitis. Ann Allergy. 1988;60:537-540.
84. Miadonna A, Tedeschi A, Leggieri E, et al. Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis. Am Rev Respir Dis. 1987;136:357-362.
85. Sri-Kantha S, Matsumura H, Kubo E, et al. Effects of prostaglandin D2, lipoxins and leukotrienes on sleep and brain temperature of rats. Prostaglandins Leukot Essent Fatty Acids. 1994;51:87-93.
86. Bellia V, Bonanno A, Cibella F, et al. Urinary leukotriene E4 in the assessment of nocturnal asthma. J Allergy Clin Immunol. 1996;97:735-741.
87. Krouse HJ, Davis JE, Krouse JH. Immune mediators in allergic rhinitis and sleep. Otolaryngol Head Neck Surg. 2002;126:607-613.
88. Kushikata T, Fang J, Krueger JM. Interleukin-10 inhibits spontaneous sleep in rabbits. J Interferon Cytokine Res. 1999;19:1025-1030.
89. Kushikata T, Fang J, Wang Y, Krueger JM. Interleukin-4 inhibits spontaneous sleep in rabbits. Am J Physiol. 1998;275:R1185-R1191.
90. Kubota T, Fang J, Kushikata T, Krueger JM. Interleukin-13 and transforming growth factor-beta1 inhibit spontaneous sleep in rabbits. Am J Physiol Regul Integr Comp Physiol. 2000;279:R786-R792.
91. von Kanel R, Dimsdale JE, Ancoli-Israel S, et al. Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer's disease. J Am Geriatr Soc. 2006;54:431-437.
92. Mullington JM, Hinze-Selch D, Pollmacher T. Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions. Ann N Y Acad Sci. 2001;933:201-210.
93. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab. 1999;84:2603-2607.
94. Mullol J, Xaubet A, Lopez E, Roca-Ferrer J, Picado C. Comparative study of the effects of different glucocorticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps. Thorax. 1995;50:270-274.
95. Opp MR, Postlethwaite AE, Seyer JM, Krueger JM. Interleukin 1 receptor antagonist blocks somnogenic and pyrogenic responses to an interleukin 1 fragment. Proc Natl Acad Sci U S A. 1992;89:3726-3730.
96. Kubota T, Brown RA, Fang J, Krueger JM. Interleukin-15 and interleukin-2 enhance non-REM sleep in rabbits. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1004-R1012.
97. Selezn'ov KH, Barynov EF, Iel's'kyi KV, Ziablitsev SV. [Interleukin-2 and interleukin-4 blood levels in sinusitis]. Fiziol Zh. 2001;47:69-73. [Ukrainian/Russian]
98. Garcia-Garcia F, Yoshida H, Krueger JM. Interleukin-8 promotes non-rapid eye movement sleep in rabbits and rats. J Sleep Res. 2004;13:55-61.
99. Bauer J, Hohagen F, Ebert T, et al. Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle. Clin Investig. 1994;72:315.
100. Hogan D, Morrow JD, Smith EM, Opp MR. Interleukin-6 alters sleep of rats. J Neuroimmunol. 2003;137:59-66.
101. Ghaffar O, Lavigne F, Kamil A, Renzi P, Hamid Q. Interleukin-6 expression in chronic sinusitis: colocalization of gene transcripts to eosinophils, macrophages, T lymphocytes, and mast cells. Otolaryngol Head Neck Surg. 1998;118:504-511.
102. Opp MR, Smith EM, Hughes TK Jr. Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep. J Neuroimmunol. 1995;60:165-168.
103. Toth LA, Opp MR. Cytokine- and microbially induced sleep responses of interleukin-10 deficient mice. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1806-R1814.
104. Jyonouchi H, Sun S, Le H, Rimell FL. Evidence of dysregulated cytokine production by sinus lavage and peripheral blood mononuclear cells in patients with treatment-resistant chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg. 2001;127:1488-1494.
105. al Ghamdi K, Ghaffar O, Small P, Frenkiel S, Hamid Q. IL-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and effect of topical corticosteroid treatment. J Otolaryngol. 1997;26:160-166.
106. Reh DD, Ramanathan M Jr, Sultan B, Wang Y, May L, Lane AP. The role of hepatocyte growth factor/c-Met in chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2010;24:266-270.
107. Kubota T, Kushikata T, Fang J, Krueger JM. Nuclear factor-kappaB inhibitor peptide inhibits spontaneous and interleukin-1beta-induced sleep. Am J Physiol Regul Integr Comp Physiol. 2000;279:R404-R413.
108. Xu R, Xu G, Shi J, Wen W. A correlative study of NF-kappaB activity and cytokines expression in human chronic nasal sinusitis. J Laryngol Otol. 2007;121:644-649.
109. Kubota T, Fang J, Brown RA, Krueger JM. Interleukin-18 promotes sleep in rabbits and rats. Am J Physiol Regul Integr Comp Physiol. 2001;281:R828-R838.
110. Okano M, Fujiwara T, Makihara S, et al. Characterization of IL-18 expression and release in the pathogenesis of chronic rhinosinusitis. Int Arch Allergy Immunol. 2013;160:275-286.
111. Bohnet SG, Traynor TR, Majde JA, Kacsoh B, Krueger JM. Mice deficient in the interferon type I receptor have reduced REM sleep and altered hypothalamic hypocretin, prolactin and 2′, 5′-oligoadenylate synthetase expression. Brain Res. 2004;1027:117-125.
112. Kubota T, Majde JA, Brown RA, Krueger JM. Tumor necrosis factor receptor fragment attenuates interferon-gamma-induced non-REM sleep in rabbits. J Neuroimmunol. 2001;119:192-198.
113. Shin SH, Ponikau JU, Sherris DA, et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol. 2004;114:1369-1375.
114. Kou W, Hu GH, Yao HB, et al. Regulation of transforming growth factor-beta1 activation and expression in the tissue remodeling involved in chronic rhinosinusitis. ORL J Otorhinolaryngol Relat Spec. 2012;74:172-178.
115. Perez-Novo CA, Claeys C, Van Cauwenberge P, Bachert C. Expression of eicosanoid receptors subtypes and eosinophilic inflammation: implication on chronic rhinosinusitis. Respir Res. 2006;7:75.
116. Wisor JP, Clegern WC, Schmidt MA. Toll-like receptor 4 is a regulator of monocyte and electroencephalographic responses to sleep loss. Sleep. 2011;34:1335-1345.
117. Sartorius T, Lutz SZ, Hoene M, et al. Toll-like receptors 2 and 4 impair insulin-mediated brain activity by interleukin-6 and osteopontin and alter sleep architecture. FASEB J. 2012;26:1799-1809.
118. Lane AP, Truong-Tran QA, Myers A, Bickel C, Schleimer RP. Serum amyloid A, properdin, complement 3, and toll-like receptors are expressed locally in human sinonasal tissue. Am J Rhinol. 2006;20:117-123.
119. Hayaishi O, Urade Y. Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. Neuroscientist. 2002;8:12-15.
120. Urade Y, Hayaishi O. Prostaglandin D2 and sleep/wake regulation. Sleep Med Rev. 2011;15:411-418.
121. Krueger JM, Kapas L, Opp MR, Obal F Jr. Prostaglandins E2 and D2 have little effect on rabbit sleep. Physiol Behav. 1992;51:481-485.
122. Zhang SQ, Inoue S, Kimura M. Sleep-promoting activity of prolactin-releasing peptide (PrRP) in the rat. Neuroreport. 2001;12:3173-3176.
123. Obal F Jr, Garcia-Garcia F, Kacsoh B, et al. Rapid eye movement sleep is reduced in prolactin-deficient mice. J Neurosci. 2005;25:10282-10289.
124. Platt MP, Soler ZM, Kao SY, Metson R, Stankovic KM. Topographic gene expression in the sinonasal cavity of patients with chronic sinusitis with polyps. Otolaryngol Head Neck Surg. 2011;145:171-175.
125. Chen L, Majde JA, Krueger JM. Spontaneous sleep in mice with targeted disruptions of neuronal or inducible nitric oxide synthase genes. Brain Res. 2003;973:214-222.
126. Cespuglio R, Amrouni D, Meiller A, Buguet A, Gautier-Sauvigne S. Nitric oxide in the regulation of the sleep-wake states. Sleep Med Rev. 2012;16:265-279.
127. Zhang Y, Endam LM, Filali-Mouhim A, Bosse Y, Castano R, Desrosiers M. Polymorphisms in the nitric oxide synthase 1 gene are associated with severe chronic rhinosinusitis. Am J Rhinol Allergy. 2011;25:e49-e54.